MEDIUM confidence: 100% data completeness, but the composite (56) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $20.8B— | $23.7B+14.1% | $21.4B-10.0% | $21.0B-1.8% | $22.4B+6.8% |
| EPS (dil.) | $7.04— | $8.14+15.6% | $8.10-0.5% | $7.97-1.6% | $8.08+1.4% |
| Free Cash Flow | $685M— | $1.2B+76.5% | $1.5B+20.1% | $1.2B-20.4% | $1.1B-5.8% |
| Gross Margin | 17.1% | 19.7%+2.6pp | 21.8%+2.0pp | 21.9%+0.2pp | 21.7%-0.2pp |
| Operating Margin | 6.8% | 7.3%+0.5pp | 7.9%+0.6pp | 7.9%+0.0pp | 7.4%-0.5pp |
| Net Margin | 4.7% | 4.7%-0.1pp | 5.2%+0.5pp | 5.1%-0.0pp | 4.8%-0.4pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $157 avg across 3 analysts.
Buy-rated share 58% → 70% over ~3 months (+12pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $2.80 | $2.91 | +3.9% |
| May 2026 | $2.28 | $2.28 | +0.0% |
| Feb 2026 | $2.44 | $2.57 | +5.3% |
| Nov 2025 | $2.62 | $2.71 | +3.4% |
| Aug 2025 | $2.49 | $2.60 | +4.4% |
| May 2025 | $1.96 | $2.15 | +9.7% |
| Feb 2025 | $2.33 | $2.48 | +6.4% |
| Oct 2024 | $2.86 | $2.63 | -8.0% |
Net insider -$1.2M over 180 days (2 open-market buys, 1 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 5.0%/yr (revenue basis).
Base free cash flow $1.2B (avg FY2023–FY2025; latest year $1.1B) · equity value $17.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 56 for CDW indicates a neutral outlook, driven by mixed category scores. The stock scores high on risk, with a low beta and moderate volatility, but lags in growth, due to slowing revenue and earnings expansion. CDW's value score is moderate, reflecting a P/E of 16.5, while its momentum score is supported by a recent 37.3% three-month return, despite a -16.0% decline over the past year.